He was scheduled for a magnetic resonance angiography for further evaluation.
He has had some constipation secondary to Percocet for which he was treated with lactulose.
Chemotherapy has included Auguron, MMP inhibitor  with concurrent gemcitabine and cisplatin times six cycles, Iressa from [**2170-5-18**] to [**2171-7-18**], Taxotere times four cycles from [**2170-8-18**] to [**2170-11-17**], radiation therapy in [**2171-7-18**], and most recently Taxotere times two cycles (with the last approximately two weeks ago).
OxyContin 20 mg p.o.
IMPRESSION: The patient is a 59-year-old male with non-small-cell lung cancer with metastases to liver and bone now with magnetic resonance imaging consistent with carcinomatous meningitis with metastases to left cerebellum, left thalamus, and frontal lobes.
He was started on Decadron at that point.
The following morning, he was brought to the operating room (per Neurosurgery), and a ventriculoperitoneal shunt/Ommaya was placed on [**2171-11-4**].
He tolerated the procedure well and had a uneventful Surgical Intensive Care Unit course.
His Decadron was tapered to 2 mg p.o.
As he had some difficulty with opiates causing mental status changes prior to surgery, opiate pain medications were limited at this point.
He was continued on a CIWA scale; however, he did not require any Ativan per protocol.
ONCOLOGY:  Per Neurosurgery, the Ommaya may be used for intrathecal chemotherapy which will be coordinated by Dr. [**Last Name (STitle) 724**] in Neurology/Oncology.
Increased intracranial pressure; status post ventriculoperitoneal shunt.
Status post repeat ventriculoperitoneal shunt placed on [**2171-11-4**].
Decadron 2 mg p.o.
Protonix 40 mg p.o.
Colace liquid 100 mg p.o.
Lactulose 30 cc p.o.
Senna one tablet p.o.
The patient was discharged to home after clearance by Physical Therapy and was to receive two sessions of [**First Name (Titles) 3429**] [**Last Name (Titles) 11807**] for ventriculoperitoneal shunt wound care.
